Jd Health International Stock Buy Hold or Sell Recommendation
| JDHIF Stock | USD 3.13 0.00 0.00% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding JD Health International is 'Hold'. Macroaxis provides JD Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding JDHIF positions.
Check out JD Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as JDHIF and provide practical buy, sell, or hold advice based on investors' constraints. JD Health International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
JDHIF |
Execute JD Health Buy or Sell Advice
The JDHIF recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on JD Health International. Macroaxis does not own or have any residual interests in JD Health International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute JD Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
JD Health Trading Alerts and Improvement Suggestions
| JD Health generated a negative expected return over the last 90 days | |
| The company reported the revenue of 30.68 B. Net Loss for the year was (1.07 B) with profit before overhead, payroll, taxes, and interest of 7.2 B. | |
| About 68.0% of the company shares are held by company insiders |
JD Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to JD Health or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that JD Health's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a JDHIF pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
JD Health Volatility Alert
At this time JD Health International exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure JD Health's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact JD Health's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.JD Health Fundamentals Vs Peers
Comparing JD Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze JD Health's direct or indirect competition across all of the common fundamentals between JD Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as JD Health or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of JD Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing JD Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare JD Health to competition |
| Fundamentals | JD Health | Peer Average |
| Return On Equity | -0.0097 | -0.31 |
| Return On Asset | -0.0099 | -0.14 |
| Profit Margin | (0.01) % | (1.27) % |
| Operating Margin | (0.02) % | (5.51) % |
| Current Valuation | 29.92 B | 16.62 B |
| Shares Outstanding | 3.18 B | 571.82 M |
| Shares Owned By Insiders | 68.29 % | 10.09 % |
| Shares Owned By Institutions | 10.16 % | 39.21 % |
| Price To Book | 4.24 X | 9.51 X |
| Price To Sales | 1.21 X | 11.42 X |
| Revenue | 30.68 B | 9.43 B |
| Gross Profit | 7.2 B | 27.38 B |
| EBITDA | (895.49 M) | 3.9 B |
| Net Income | (1.07 B) | 570.98 M |
| Cash And Equivalents | 45.68 B | 2.7 B |
| Cash Per Share | 14.37 X | 5.01 X |
| Total Debt | 194.3 M | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 4.89 X | 2.16 X |
| Book Value Per Share | 13.33 X | 1.93 K |
| Cash Flow From Operations | 3.43 B | 971.22 M |
| Earnings Per Share | (0.05) X | 3.12 X |
| Number Of Employees | 2.54 K | 18.84 K |
| Beta | 0.49 | -0.15 |
| Market Capitalization | 30.5 B | 19.03 B |
| Total Asset | 48 B | 29.47 B |
| Z Score | 93.6 | 8.72 |
| Net Asset | 48 B |
JD Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as JDHIF . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About JD Health Buy or Sell Advice
When is the right time to buy or sell JD Health International? Buying financial instruments such as JDHIF Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having JD Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run IT Thematic Idea Now
IT
Information Technology (IT) companies and IT service providers across different domains. The IT theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize IT Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in JDHIF Pink Sheet
JD Health financial ratios help investors to determine whether JDHIF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in JDHIF with respect to the benefits of owning JD Health security.